On Thursday May 2, 2019 UMC Utrecht and Olink held a symposium, “A proteomics perspective on Precision Medicine”. Around 60 scientists attended the event, which featured a series of outstanding presentations and an engaged and knowledgeable audience.
The five customer talks covered a wide variety of disease fields and applications. In the keynote lecture, Linn Fagerberg (KTH, Sweden) showed why proteomics is key to drive precision medicine forward. Then Marijana Rucevic (Olink Proteomics, USA) discussed how liquid biopsy using plasma proteomic profiling can reveal predictors of immunotherapy response. Isabella Kardys (Erasmus MC, NL) highlighted protein profiling in chronic heart failure and how their findings could potentially contribute to personalized monitoring and treatment strategies.
After the coffee break, Stefan Nierkens (UMCU, NL) showed that Olink is a promising tool for biomarker research, even in rare chronic inflammatory diseases, but that cohorts need to be thoroughly defined. In the final talk on finding diagnostic markers for different types of dementia, Marta del Campo-Milan (Amsterdam UMC, NL) explained why they believe Olink is such a promising approach from discovery all the way up to a future clinical test.
Olink was delighted to be involved with this event, enabling scientists in the Netherlands to hear about these exciting developments in protein biomarker research for precision medicine. We would like to sincerely thank our co-organizers, our outstanding speakers and of course, all who attended the symposium and contributed to making it a success!